Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder"

被引：0
|
作者：
Strawn, Jeffrey R. [1 ,2 ]
Mills, Jeffrey A. [1 ]
机构：
[1] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA
[2] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45219 USA
来源：
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 2024年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Placebo-Controlled Double-Blind Trial of Cannabinoids in Children and Adolescents With Autism Spectrum Disorder
    Castellanos, Francisco
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 61 - 62
  • [22] A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ESCITALOPRAM IN ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER
    Strawn, Jeffrey Robert
    Mills, Jeffrey A.
    Schroeder, Heidi K.
    Mossman, Sarah
    Varney, Sara T.
    Ramsey, Laura A.
    Cecil, Kim
    Delbello, Melissa P.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S254 - S254
  • [23] Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial
    Lu, Lu
    Mills, A. Jeffrey
    Li, Hailong
    Schroeder, K. Heidi
    Mossman, A. Sarah
    Varney, T. Sara
    Cecil, M. Kim
    Huang, Xiaoqi
    Gong, Qiyong
    Ramsey, B. Laura
    DelBello, P. Melissa
    Sweeney, A. John
    Strawn, R. Jeffrey
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : 1309 - 1318
  • [24] A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder
    Rickels, K
    DeMartinis, N
    Aufdembrinke, B
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (01) : 12 - 18
  • [25] Efficacy and Safety of Vilazodone in Generalized Anxiety Disorder: A Randomized, Double-blind, Placebo-controlled Trial
    Thase, Michael E.
    Mathews, Maju
    Forero, Giovanna
    Nunez, Rene
    Chen, Changzheng
    Gommoll, Carl
    Durgam, Suresh
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S344 - S344
  • [26] Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study
    Rickels, K
    Zaninelli, R
    McCafferty, J
    Bellew, K
    Iyengar, M
    Sheehan, D
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04): : 749 - 756
  • [27] Tiagabine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study
    Pollack, M
    Van Ameringen, M
    Snyder, H
    Brown, C
    Ondrasik, J
    Roy-Byrne, P
    Rickels, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S538 - S538
  • [28] Adjunctive risperidone in generalized anxiety disorder: A double-blind, placebo-controlled study
    Brawman-Mintzer, O
    Knapp, RG
    Nietert, PJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1321 - 1325
  • [29] The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
    Wang, Xiaoliang
    Fan, Yimin
    Li, Guanjun
    Li, Huafang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 133 - 139
  • [30] A randomized, double-blind, placebo-controlled study of escitalopram in patients with social anxiety disorder in Japan
    Asakura, Satoshi
    Hayano, Taiji
    Hagino, Atsushi
    Koyama, Tsukasa
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (04) : 749 - 757
12345